Page 129 - D. Cancer biology
P. 129

Anti-tumor Effects of Persimmon Leaves(Diospyros kaki) Extract via PDGFR-Rac-JNKs pathway
                                 1
                     1
           Heon-Su Kim , Jung-Soo Suh , Yoon-Kwan Jang , Sang-Hyun Ahn , Ganesan Raja and Tae-Jin Kim 1, 2*
                                                                         2
                                                             1
                                                1
               1 Department of Integrated Biological science, Pusan National Unversity, Pusan 46241, Korea (Republic of)
                  2 Department of Biological Sciences, Pusan National Unversity, Pusan 46241, Korea (Republic of)
                   BACKGROUND                                                  AIM
    The persimmon leaves are well known for potential beneficial effects, including
   ROS elimination, lipid circulation, neuronal protection. However, their biological
   and/or biochemical pathways are not well understood at the cellular level. Herein,
   we found that a high concentration of ethanol extract of Diospyros kaki (EEDK)
   treatment can cause cancer cell death, and inhibit cell proliferation. In particular,
   HepG2 (hepatocellular carcinoma cell line) is more vulnerable to EEDK
   administration  than HEK293  (human embryonic kidney cell line).  Using
   fluorescence resonance energy transfer (FRET) technology, we first observed that
   EEDK stimulates PDGFR-Rac signaling cascade in living cells. It was further
   revealed that JNKs, downstream of PDGFR-Rac pathway, was activated by EEDK.
   In contrast, JNK-downstream inhibitors, such as CoCl2, T-5224 and Pepstatin A,
   attenuated the EEDK-inducing cell death. Thus, our results indicate that PDGFR-
   Rac-JNK signaling triggered by EEDK leads to cancer cell death, suggesting the
   persimmon leaves could be a promising anti-tumor agent.
                                       Materials and Methods
   •  Ethanol Extract of Diospyros kaki(EEDK) was kindly provided by Dr. Sang Hoon Jung(Korea Institute of Science and Technology,
      Republic of Korea). EEDK was dissolved in dimethyl sulfoxide(DMSO) and treated to cells. DMSO was used as a control, and
      final DMSO concentration did not exceed 0.5%(v/v).
   •  HepG2 and HEK293A cells were cultured in Dulbecco’s modified Eagle’s medium supplemented with 10% Fetal Bovine
      Serum, 100U/ml penicillin and 100μg/ml streptomycin and incubated in a humidified incubator of 95% O 2 and 5% CO 2 at 37℃.
   •  To investigate the cell’s viability, proliferation and protein’s activity, we performed Viability assay(WST-8 assay), Clonogenic
      assay and Luciferase assay, respectively.
   •  Cells expressing several exogenous proteins were cultured in Confocal Dish. During imaging, medium was changed with CO 2 -
      independent medium containing 0.5% FBS. Images were obtained by a Leica DMi8 microscope equipped with a charge-coupled
      device(CCD) camera. LAS X software was used to acquire images, compute the emission ratio of ECFP/FRET. Specific region
      of target cells were selected as a region of interest(ROI) to observe signals and implement a quantification.
                                                RESULTS
   (A)               (B)               Time      Kras PDGFR Biosensor    (A)              (B)
     120  *  ***  **  H E K 293A  120  *  **  ***  ***  **  H ep G 2  (min)  0  10  20  30  40  5 4  C o n tro l  **  H E K 293A  2.0 1.5  C o n tro l  **  H ep G 2
                                    #
                   #
                 **
    %  V ia b ility  o f c e lls  80 60 40  %  V ia b ility  o f c e lls  80 60 40  Control  1.5  FRET ratio  A P -1 R e lative  L u c ifera se  ac tivity  3 2  A P -1 R e lative  L u c ifera se  ac tivity  1.0 0.5
                                                                             50 µ g /m l E E D K
                                                                                              50 µ g /m l E E D K
                      100
     100
                                        (A)
     0 20              20 0             (B)                         20μm  2.0 0  1 0       0.0
      C ontrol 0 .1  1  10  50  75  100  C ontrol 0 .1  1  10  50  75  100  (C)           (D)
            EED K (µ g /m l)  EED K (µ g /m l)  EEDK                    FRET ratio  1.5  C o n tro l  H E K 293A  1.5  C o n tro l  H ep G 2
   (C)                  EEDK (μg/ml)                                          50 µ g /m l E E D K  50 µ g /m l E E D K
                                                                     20μm
                                                                       0.65  1.0           1.0
            Control    50       100     (C) 1 .6  C o n tro l  (D)  C o n tro l  K r as  P D G F R  B io sen so r  N F A T R e lative  L u c ifera se  ac tivity  0.5  **  N F A T R e lative  L u c ifera se  ac tivity  0.5
                                          N orm a liz e d C F P /FR E T ra tio  1 .4 1 .2  E ED K  1 .5 1 .0  E ED K  *  0.0  0.0  **
    HEK293A                               1 .0            N orm a liz e d C F P /FR E T ra tio  0 .5  Figure 5 Effects of EEDK on DNA binding activity  of AP-1 and NFAT. (A-B) AP-1 activity
                                                                          of (A) HEK293A and (B) HepG2 cells exposed  to Control(0.5% DMSO) and
                                          0 .8
                                                                          D) NFAT activity of (C) HEK293A and (D) HepG2 cells exposed to Control(0.5%  DMSO)
                                           0
                                             6
                                              8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40
                                            2
                                            4
                                                T im e (m in ) K r as  P D G F R  B io sen so r  0 .0  0 m in  40m in  EEDK(50μg/ml) for 24h. Cells were transfected with 3xAP1pGL3  (40342, addgene). (C-
                                                                          and EEDK(50μg/ml) for 24h. Cells were transfected with pGL3-NFAT luciferase(17870,
                                         Figure 3 Effects of EEDK on PDGFR activity. (A-B) Time-lapse  FRET images of Kras-  addgene). The bar graphs shown are mean values of relative  Luminescence  with error
                                         PDGFR biosensor in HEK293A exposed to Control(0.5% DMSO) and EEDK(50μg/ml).   bars indicating the S.E.M(n=3, **p<0.01, Student t test). Luminescence  values are
                                         The color scale bars represent  the range  of ECFP/FRET emission  ratio of biosensors.   detected  by Glomax TM Multi+Microplate Multi Reader(9301-010;Promega,USA)
    HepG2                                Hot and cold colors indicate  high and low PDGFR activity,  respectively.  (C) The time   (A)  (B)
                                         courses represent the average  of nomalized ECFP/FRET emission ratio changes of
                                         PDGFR biosensor.  The dots shown are mean  values of normalized emission ratio with   150  H E K 293A  150  H ep G 2
                                         error bars indicating S.E.M(n=7).  (D) The bar graph describes mean  values of normalized
                                         ECFP/FRET emission ratio of biosensor at 0 min and 40 min. It also contains error bars   #  #  **
                                         indicating the S.E.M(n=7, *p<0.05, Student t test)  100  100  ** *
   (D)               (E)               Time         Rac Biosensor          %  V ia b ility  o f c e lls  %  V ia b ility  o f c e lls  50
     300               200         H ep G 2 (min)                           50
                 H E K 293A  150        (A)  0    10    20    30   40  0.48     EEDK   0  -   -   -   +   -   +   +   +   -   -      EEDK   0  -   -   -   +   -   +   +   +   -   -
    N um be r of c o lon ie s  200  N um be r of c o lon ie s  100 50  Control  20μm  0  FRET ratio  Anisomycin   -  -  -   -  +  -   -  -  +   -  -  -   +  -  -   +  -  -   +  -  -   -  -  +   +  +  -   -  +  +   Anisomycin   -  -  -   -  +  -   -  -  +   -  -  -   +  -  -   +  -  -   -  +  -   -  -  +   +  +  -   -  +  +
                                                                          CoCl2
                                                                                          CoCl2
                                                                          T-5224
                                                                                          T-5224
                                                                                          (D)
                                                                          (C)
     100
     0                 0                (B)                          20μm  0.85  150  ** *  ** * H E K 293A  150  #  *  H ep G 2
        C ontrol  50  100  C ontrol  50  100  EGF                       FRET ratio  100     100
             EED K (µ g /m l)  EED K (µ g /m l)                             %  V ia b ility  o f c e lls  %  V ia b ility  o f c e lls
    Figure 1. Effects of EEDK on cell death and proliferation. (A-B)Viability of (A)HEK293A and   50  50
    (B)HepG2 cells exposed to Control(0.5%  DMSO) and EEDK(0.1 to 100μg/ml) for 24h, as   0
    measured in Viability  assay. The bar graphs describe mean  values of cell viability  with error  bars   (C)  1.05
    indicating the S.E.M(n=3, *p<0.05, **p<0.01, ***p<0.001, and  # p<0.0001, Student t test) (C)   0  0
    Clonogenic assay images of HEK293A and HepG2 cells exposed to Control(0.5%  DMSO) and   EEDK  FRET ratio  EEDK   -   +   +   -   EEDK   -   +   +   -
    EEDK(50, 100μg/ml)  for 36h, and media are changed with growth media.  (D-E) The bar graphs   Pepstatin A   -   -   +   +   Pepstatin A   -   -   +   +
    shown are number  of colonies.  Colonies’  pixel is >20, circularity is 0.2 - 1.0 . Quantification of   20μm     Figure 6 Effects of EEDK on cell death  is dependent  on JNK-AP-1/p-53 activity.  (A-B)

    cell colonies was measured  with Image  J.                         0  Viability of (A)HEK293A and (B)HepG2 cells treated with/without Control(0.5%  DMSO),
    (A)  2 .5  C o n tro l  *  H E K 293A  (B)  2 .0  C o n tro l  *  H ep G 2  (D)  3 .0 2 .5  C o n tro l  (E)  3.5 3.0  C o n tro l  R ac B io se n s o r  EEDK(100μg/ml),  Anisomycin(JNK activatior, 4μM), CoCl2(Hypoxia mimicking
                                                                          agent,150μM)  and T-5224(AP-1 inhibitor,  10μM) for 24h, as measured in Viability  assay.
      R elative  F lu o re sc en ce  In te n s ity  1 .0  R elative  F lu o re sc en ce  In te n s ity  0 .5  1 .0  R ac B io se n s o r  1.0 0.5  cell viability with error bars indicating the S.E.M(n=4 (A,B) or 3 (C,D), *p<0.05 , **p<0.01,
                                                                          (C-D) Viability  of (A)HEK293A and (B)HepG2 cells treated  with/without Control(0.5%
                                            EG F
                                                                    #
                                                              EG F
                                            E ED K
                                                                     #
                                                                          DMSO), EEDK(100μg/ml)  and Pepstatin A(aspartic proteases inhibitor, 1μM) for 24h, as
                                                                          apoptosis. Anisomycin was used as a positive  control. Pepstatin A is known as
     Fluo -3  2 .0 1 .5  50 µ g /m l E E D K  Fluo -3  1 .5 1 .0  50 µ g /m l E E D K  N orm a liz e d C F P /FR E T ra tio  2 .0 1 .5  N orm a liz e d C F P /FR E T ra tio  2.5 2.0 1.5  E ED K  **  measured in Viability  assay. Pepstatin A is known as suppressor  of p53, TNF-α induced
                                                                          suppressor of p53, TNF-α induced apoptosis. The bar graphs shown are mean values  of
                                                                          ***p<0.001 and  # p<0.0001, Student t test)
                                                            0.0
                                             4
                                             6
                                           0
                                            2
                                              8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40
                                                                    40m in
                                                               0m in
                                                 T im e (m in )
    (C)  0 .5 0 .0   (D)  0 .0           Figure 4 Effects of EEDK on Rac activity. (A-C) Time-lapse  FRET images of Rac bisensor in   CONCLUSION
                                         HEK293A exposed  to Control(0.5% DMSO), EEDK(50μg/ml) and EGF(100ng/ml).  EGF was
      2 .5 2 .0  C o n tro l  *  H E K 293A  2 .5 2 .0  C o n tro l  **  H ep G 2  used as a positive control. The color scale bars represent the range  of ECFP/FRET emission
                                         ratio of biosensors.  Hot and cold colors indicate  high and low Rac activity, respectively. (D)
                                         The time courses represent  the average of nomalized ECFP/FRET emission  ratio changes of
         50 µ g /m l E E D K
                           50 µ g /m l E E D K
     β T rC P-EYF P R elative  F lu o re sc en ce  In te n s ity  1 .5 1 .0 0 .5  β T rC P-EYF P R elative  F lu o re sc en ce  In te n s ity  1 .5 1 .0  Rac biosensor. The dots shown are mean values  of normalized emission  ratio with error  bars
                                         indicating the S.E.M(n=8) (E) The bar graph describes mean values of normalized
                                         ECFP/FRET emission ratio of biosensor at 0min and 40min. It also contains error  bars
                                         indicating the S.E.M(n=8, **p<0.01,  # p<0.0001)
                                                                                 REFERENCES
                        0 .5
      0 .0
                        0 .0
    Figure 2 Effects of EEDK on intracellular  Ca 2+ concentration and βTrCP-EYFP expression. (A-B)   ACKNOWLEDGEMENTS  Kim, K.-A. et al. Leaves of persimmon (Diospyros kaki Thunb.) ameliorate N-methyl-N-
    Intracellular Ca 2+ concentration  of (A) HEK293A and (B) HepG2 cells exposed  to Control(0.5%   This research was supported by Basic Science Research Program  nitrosourea (MNU)-induced retinal degeneration in mice. J. Agric. Food Chem. 63, 7750–
    DMSO) and EEDK(50μg/ml) for 8h, as measured in Fluo-3 assay. (C-D) βTrCP-EYFP expression of   through the National Research Foundation of Korea (NRF) funded  7759 (2015).
    (C) HEK293A and (D) HepG2 cells exposed to Control(0.5% DMSO) and EEDK(50μg/ml) for 24h.   Ahn, H. R. et al. Persimmon leaves (Diospyros kaki) extract protects optic nerve crush-
    Fluorescence values of Ca 2+ -Fluo-3  complex and expressed βTrCP-EYFP are detected with   by the Ministry of Education (2017R1D1A1B03035622).  induced retinal degeneration. Sci. Rep. 7, 46449 (2017).
    Glomax TM Multi+Microplate Multi Reader(9301-010;Promega,USA). The bar graphs describe mean
    values of relative fluorescence with error bars indicating the S.E.M(n=3, *p<0.05, **p<0.01, Student
    t test)
   124   125   126   127   128   129   130   131   132   133   134